Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Oxcarbazepine I.P. 300mg Tablet
Therapeutic Category
Antiepileptic, Neurology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹229/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Oxcelzine 300 Tablet contains Oxcarbazepine I.P. 300mg, an anticonvulsant medication primarily used to manage epilepsy and prevent seizures. It works by stabilizing electrical activity in the brain, thereby reducing the frequency and severity of seizures. Oxacrip 300 is also beneficial in managing other conditions like partial seizures and is often used as an adjunctive therapy for epilepsy. Its mechanism of action involves blocking sodium channels in the brain, which helps control the electrical impulses that lead to seizures.
Oxcarbazepine, the active ingredient in Oxacrip 300, is known for its efficacy in controlling seizure activity. It is commonly prescribed to patients who have not responded well to other antiepileptic drugs or require additional treatment for seizure management. Oxacrip 300 also plays a role in managing mood disorders like bipolar disorder, where it helps stabilize mood fluctuations. The medication is typically taken in tablet form and is absorbed into the bloodstream, where it begins to take effect in controlling seizure activity.
Patients taking Oxcelzine 300 Tablet may experience significant improvements in seizure control and quality of life, especially when used in conjunction with other antiepileptic medications. As with any anticonvulsant therapy, the dosage should be carefully tailored to each individual, with close monitoring to avoid side effects and interactions with other drugs.
Common side effects may include dizziness, fatigue, nausea, and headache. More serious side effects include skin reactions, hyponatremia (low sodium), and allergic reactions. Consult a healthcare provider if any severe symptoms arise.
Oxacrip 300 is indicated for the treatment of partial seizures in epilepsy, as well as for use as an adjunct in combination therapy for generalized seizures.
Take Oxacrip 300 as prescribed by your doctor; sudden discontinuation may increase the risk of seizures.
Store in a cool, dry place, away from direct sunlight, and out of reach of children.
Composition : Neurological Disorder Syrup
Composition : Divalproex (250mg) Prolonged Release
Composition : Gabapentin (400mg) + Nortriptyline Hydrochloride (10mg)
Composition : Sodium Valproate I.P. 133mg + Valproic Acid I.P. 58mg (C.R.)
Composition : Sodium Valproate 200mg + Valproic Acid 87mg
Composition : Sodium Valproate (333mg) + Valproic Acid (145mg) Tablet
Composition : Brivaracetam I.P. 100mg Tablet
Composition : Brivaracetam I.P. 50mg Tablet
Composition : Divalproex (500mg) Prolonged Release Tablet
Composition : Duloxetine (20mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Oxcarbazepine Tablets have strong demand in the neurology and CNS segment, making them a high-potential product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for epilepsy (partial seizures) and mood stabilization in certain psychiatric conditions, ensuring consistent long-term prescription-based demand.
Medical distributors and agencies benefit from the chronic therapy and specialist prescription nature of epilepsy treatment. Used in management of partial seizures and epilepsy control Helps stabilize neuronal activity and reduce seizure frequency Also used as mood stabilizer in bipolar disorder (physician-guided use) Widely prescribed by neurologists and psychiatrists Strong demand due to lifelong or long-term therapy requirement Ensures regular monthly repeat prescriptions and stable sales This makes it a high-retention and consistent CNS segment product.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Oxcarbazepine 300 mg Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from consistent neurology prescription demand, strong chronic-care usage, repeat monthly sales, and long-term stability in the CNS therapeutic segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete neurology product portfolio access to build a strong presence in the epilepsy and CNS care market.